Press Releases Archives - Page 19 of 103 - Lupin

BSE 2328.10 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2328.10 NSE 2324.50

Lupin Receives Approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.07%

November 23, 2023

Lupin Receives Tentative Approval from U.S. FDA for Canagliflozin Tablets

November 23, 2023

Lupin Launches World’s First Fixed-dose Triple Combination Drug, Vilfuro-G® for COPD Management in India

November 23, 2023

Lupin Receives Approval from U.S. FDA for Pitavastatin Tablets

November 21, 2023

Lupin Receives Tentative Approval from U.S. FDA for Dapagliflozin Tablets

November 21, 2023

Lupin Receives Approval from U.S.FDA for Ganirelix Acetate Injection

November 17, 2023

Lupin and Amman Pharma Sign Exclusive Licensing and Supply Agreement for Ranibizumab Biosimilar

November 10, 2023

Lupin Q2 FY2024 Results

November 8, 2023

Lupin Launches Rocuronium Bromide Injection in the United States

November 8, 2023

Lupin Receives Tentative Approval from U.S. FDA for Canagliflozin and Metformin Hydrochloride Extended-Release Tablets

November 7, 2023

1 2 … 18 19 20 … 102 103

Search

Hit enter to search or ESC to close